Search research articles
Contact Us
Filters
Showing results (261-270 of 785) with videos related to
Page
of 79
Sort By:
Plos One
|
November 25, 2015
Left Ventricular Geometry and Blood Pressure as Predictors of Adverse Progression of Fabry Cardiomyopathy
Johannes Krämer, Bart Bijnens, Stefan Störk, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
January 31, 2007
Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis
Vera Krane, Detlef H Krieter, Manfred Olschewski, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
February 26, 2004
Advanced renal insufficiency in a 34-year-old man with Lowe syndrome
Lothar Schramm, Andreas Gal, Josef Zimmermann, et al.
Kidney Medicine
|
April 7, 2022
Validation of a United Kingdom Model to Predict Mortality in Incident Dialysis Patients in the Dialysis Outcomes and Practice Patterns Study Cohort: Introduction of a Clinical Risk Score
Martin Wagner, David M Kent, Ronald L Pisoni, et al.
Diabetologia
|
May 2, 2018
Empagliflozin in women with type 2 diabetes and cardiovascular disease - an analysis of EMPA-REG OUTCOME®
Bernard Zinman, Silvio E Inzucchi, Christoph Wanner, et al.
Diabetes, Obesity & Metabolism
|
March 18, 2022
Empagliflozin and incidence of events consistent with acute kidney injury: Pooled safety analysis in more than 15 000 individuals
Rajiv Agarwal, Sibylle Jenny Hauske, David C Wheeler, et al.
Molecular Genetics and Metabolism
|
December 3, 2010
Expert opinion on temporary treatment recommendations for Fabry disease during the shortage of enzyme replacement therapy (ERT)
Gabor E Linthorst, Dominique P Germain, Carla E M Hollak, et al.
Plos One
|
May 20, 2021
COVID-19 and the kidney: A retrospective analysis of 37 critically ill patients using machine learning
Anna Laura Herzog, Holger K von Jouanne-Diedrich, Christoph Wanner, et al.
Circulation
|
October 26, 2018
Improvement in Cardiovascular Outcomes With Empagliflozin Is Independent of Glycemic Control
Silvio E Inzucchi, Mikhail Kosiborod, David Fitchett, et al.
Diabetes Care
|
August 28, 2012
Transthyretin predicts cardiovascular outcome in hemodialysis patients with type 2 diabetes
Andrea Henze, Katharina M Espe, Christoph Wanner, et al.
Page
of 79
Search research articles
Search
Showing results (261-270 of 785) with videos related to
Sort By:
Page
of 79
Plos One
|
November 25, 2015
Left Ventricular Geometry and Blood Pressure as Predictors of Adverse Progression of Fabry Cardiomyopathy
Johannes Krämer, Bart Bijnens, Stefan Störk, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
January 31, 2007
Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis
Vera Krane, Detlef H Krieter, Manfred Olschewski, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
February 26, 2004
Advanced renal insufficiency in a 34-year-old man with Lowe syndrome
Lothar Schramm, Andreas Gal, Josef Zimmermann, et al.
Kidney Medicine
|
April 7, 2022
Validation of a United Kingdom Model to Predict Mortality in Incident Dialysis Patients in the Dialysis Outcomes and Practice Patterns Study Cohort: Introduction of a Clinical Risk Score
Martin Wagner, David M Kent, Ronald L Pisoni, et al.
Diabetologia
|
May 2, 2018
Empagliflozin in women with type 2 diabetes and cardiovascular disease - an analysis of EMPA-REG OUTCOME®
Bernard Zinman, Silvio E Inzucchi, Christoph Wanner, et al.
Diabetes, Obesity & Metabolism
|
March 18, 2022
Empagliflozin and incidence of events consistent with acute kidney injury: Pooled safety analysis in more than 15 000 individuals
Rajiv Agarwal, Sibylle Jenny Hauske, David C Wheeler, et al.
Molecular Genetics and Metabolism
|
December 3, 2010
Expert opinion on temporary treatment recommendations for Fabry disease during the shortage of enzyme replacement therapy (ERT)
Gabor E Linthorst, Dominique P Germain, Carla E M Hollak, et al.
Plos One
|
May 20, 2021
COVID-19 and the kidney: A retrospective analysis of 37 critically ill patients using machine learning
Anna Laura Herzog, Holger K von Jouanne-Diedrich, Christoph Wanner, et al.
Circulation
|
October 26, 2018
Improvement in Cardiovascular Outcomes With Empagliflozin Is Independent of Glycemic Control
Silvio E Inzucchi, Mikhail Kosiborod, David Fitchett, et al.
Diabetes Care
|
August 28, 2012
Transthyretin predicts cardiovascular outcome in hemodialysis patients with type 2 diabetes
Andrea Henze, Katharina M Espe, Christoph Wanner, et al.
Page
of 79